We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

131 hedge funds and large institutions have $571M invested in Albany Molecular Research Inc in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more call options, than puts

Call options by funds: $3.33M | Put options by funds: $1.48M

55% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 33

18% more capital invested

Capital invested by funds: $484M → $571M (+$87.1M)

0% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 20

1% less funds holding

Funds holding: 132 → 131 (-1)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
131
Holders Change
-1
Holders Change %
-0.76%
% of All Funds
3.49%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
20
Increased
51
Reduced
33
Closed
20
Calls
$3.33M
Puts
$1.48M
Net Calls
+$1.85M
Net Calls Change
-$527K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$27.6M
2
RHJA
Rice Hall James & Associates
California
+$19.6M
3
OWP
Obermeyer Wealth Partners
Colorado
+$18.7M
4
EAM
EverPoint Asset Management
Connecticut
+$15.3M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$11.9M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$31M
2
IGM
Incline Global Management
New York
-$12.1M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6.86M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$6.68M
5
PIP
Permian Investment Partners
Texas
-$6.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
IGM
26
Incline Global Management
New York
$4.72M -$12.1M -712,804 -73%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$4.48M +$807K +47,335 +23%
GIP
28
Granite Investment Partners
California
$4.11M +$3.98M +233,416 New
Point72 Asset Management
29
Point72 Asset Management
Connecticut
$4.1M +$3.97M +233,100 New
MOACM
30
Mutual of America Capital Management
New York
$3.67M -$5.11K -300 -0.1%
Deutsche Bank
31
Deutsche Bank
Germany
$3.41M -$131K -7,703 -4%
Natixis Advisors
32
Natixis Advisors
Massachusetts
$3.09M +$769K +45,108 +35%
HA
33
Heartland Advisors
Wisconsin
$2.82M +$2.73M +160,371 New
Principal Financial Group
34
Principal Financial Group
Iowa
$2.6M +$56.3K +3,306 +2%
Geode Capital Management
35
Geode Capital Management
Massachusetts
$2.39M +$60.4K +3,546 +3%
PTC
36
Philadelphia Trust Company
Pennsylvania
$2.17M +$2.1M +123,450 New
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$2.12M – – –
CSC
38
Cove Street Capital
California
$2.11M +$341K +20,000 +20%
GC
39
Guggenheim Capital
Illinois
$2.06M +$373K +21,913 +23%
FSA
40
Franklin Street Advisors
North Carolina
$2.04M +$396K +23,250 +25%
GCP
41
GSA Capital Partners
United Kingdom
$2M +$990K +58,112 +105%
LCS
42
Levin Capital Strategies
New York
$1.99M +$1.93M +113,203 New
Ameriprise
43
Ameriprise
Minnesota
$1.93M +$82.3K +4,831 +5%
JP Morgan Chase
44
JP Morgan Chase
New York
$1.85M +$1.79M +105,150 New
AA
45
Ancora Advisors
Ohio
$1.82M -$1.76M -103,300 Closed
TCIM
46
TIAA CREF Investment Management
New York
$1.75M -$45.2K -2,655 -3%
FM
47
Forward Management
California
$1.65M -$284K -16,685 -13%
BIM
48
BlackRock Investment Management
Delaware
$1.61M +$11.9K +700 +0.8%
Bessemer Group
49
Bessemer Group
New Jersey
$1.6M – – –
BF
50
BOK Financial
Oklahoma
$1.38M +$1.34M +78,570 New
1
2
3 4 5

AMRI Hedge Fund Activity: Q1 2015 in Review

131 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q1 2015, worth a combined $571M — up 18% from $484M a quarter earlier.

Fund positioning in AMRI was balanced in Q1 2015: 20 funds opened new positions, 20 closed out, 51 added to existing stakes and 33 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $27.6M. The largest seller was Visium Asset Management, cutting an estimated $31M.

  • 131 institutional investors held Albany Molecular Research Inc (AMRI) as of Q1 2015, down from 132 in Q4 2014.
  • Funds reported $571M of Albany Molecular Research Inc stock for Q1 2015, up 18% quarter-over-quarter.
  • 20 funds opened new Albany Molecular Research Inc positions in Q1 2015 and 20 closed out, a net change of 0 holders.
  • The largest Albany Molecular Research Inc buyer in Q1 2015 was Goldman Sachs, an estimated $27.6M added.
  • The largest Albany Molecular Research Inc seller in Q1 2015 was Visium Asset Management, an estimated $31M sold.

Based on aggregated 13F filings for Q1 2015.